Conference
Baseline Clinical and Laboratory Features Predict Risk of Developing Symptomatic Thromboembolism (STE) During Antileukemic Therapy in Children with De Novo Acute Lymphoblastic Leukemia (ALL)
Authors
Athale UH; Mizrahi T; Laverdier C; Thabane L; David M; Leclerc JM; Chan A
Volume
63
Pagination
pp. S27-S27
Publisher
WILEY-BLACKWELL
Publication Date
November 1, 2016
Conference proceedings
PEDIATRIC BLOOD & CANCER
ISSN
1545-5009